Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Votrient |
|---|---|
| Manufacturer | Novartis Pharmaceuticals |
| Prescription required | Yes |
Votrient Tablets 120 x 200mg(Pazopanib)
PAZOPANIB
Description
Votrient Tablets 120 x 200mg(Pazopanib) is a medicine catalog record in the MediPriceHub database. Active ingredient: PAZOPANIB. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Novartis Pharmaceuticals. Therapeutic category: Medicine Library > Oncology Medicines > Soft Tissue Sarcoma Drugs. Pack information: 200 / 120. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
VOTRIENT is a kinase inhibitor indicated for the treatment of adults with: Limitations of Use : The efficacy of VOTRIENT for the treatment of patients with adipocytic soft tissue sarcoma or gastrointestinal stromal tumors has not been demonstrated. advanced renal cell carcinoma (RCC). advanced soft tissue sarcoma (STS) who have received prior chemotherapy.How to Use
Use PAZOPANIB under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: PAZOPANIB. Pack size: 200 / 120. Pack unit: bottle. Manufacturer: Novartis Pharmaceuticals. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Soft Tissue Sarcoma Drugs. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Esta información es solo orientativa. Consulta a un profesional sanitario antes de usar cualquier medicamento.